Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Magnitude Biosciences secures €1.5 million investment to scale its in vivo drug discovery platform. The funding, led by Northstar Ventures, will accelerate the commercialisation of VivoScan TM.

PRIVATESep 15, 2026•1 day ago

Amount Raised

€1.5 Million

Round Type

Seed

North East DistrictFinancial ServicesFinanceLendingBanking

Investors

New Angel InvestorsMaven’s Regional FundsNorthstar Ventures

Description

Magnitude Biosciences has secured €1.5 million in funding to enhance its VivoScan TM platform for drug discovery. The investment was led by Northstar Ventures and is aimed at commercializing their proprietary high-throughput screening technology. CEO Dr. Fozia Saleem expresses ambition to revolutionize drug discovery

Company Information

Company

Magnitude Biosciences

Location

North East District, Botswana

About

The British Business Bank is a government-owned development bank aimed at improving access to finance for small and medium-sized enterprises across the UK. Its Northern Powerhouse Investment Fund II (NPIF II) focuses on supporting businesses in the North East by providing loans and equity investments. The fund has successfully completed over 315 deals, driving job creation, innovation, and expansion in the region.

Don't miss Magnitude Biosciences's next move

Get an email the moment Magnitude Biosciences raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Magnitude Biosciences's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Magnitude Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.